Activity Overview
This activity is designed to help pathologists and laboratory professionals understand the key consideration when establishing a PD-L1 Laboratory Developed Test (LDT). Panelists will discuss their experiences with an LDT and explain what is involved with validation and scoring different types of cancers.
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals diagnosing cancer.
Activity Agenda
· Introductions
· Review what is involved with establishing and validating a PD-L1 laboratory developed test (LDT)
· Scoring systems
· Panel discussion: experiences with a PD-L1 LDT
· Summary of key takeaways
Learning Objectives
Upon completion of this activity, you will be able to:
· Describe how laboratories are establishing a PD-L1 laboratory developed test (LDT).
· List the key considerations around establishing a PD-L1 LDT.
· Discuss some potential limitations when using a PD-L1 LDT.
Faculty
Yin P. (Rex) Hung, M.D., Ph.D. |
Assistant Pathologist, Massachusetts General Hospital
Assistant Professor in Pathology, Harvard Medical School
Boston, Massachusetts |
Mamatha Chivukula, MD, FASCP |
Pathologist, Mills-Peninsula Medical Center, Sutter Health
Burlingame, California |
Jefree J. Schulte, MD |
Assistant Professor, Department of Pathology and Laboratory Medicine
University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin |
Joseph Kim, MD |
President of Q Synthesis LLC |
Faculty Disclosures
Yin P. (Rex) Hung, Mamatha Chivukula, Jefree J. Schulte, and Joseph Kim have no relevant financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The ASCP designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of 0.5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time.
Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CME certificates will be provided online.
Commercial Support
This activity is funded by an independent educational grant from Merck.